[1]
Y. Bustanji, “Erythropoietin Biosimilar Products and Immunogenicity: A Pharmacovigilance Study”, Int J of Pharmc Res, vol. 6, no. 6, pp. 200–205, Jun. 2016, doi: 10.7439/ijpr.v6i6.3311.